BR112017006536A2 - polipeptídeo de ligação ao anticorpo, polipeptídeo de fusão de ligação ao anticorpo, e material de adsorção - Google Patents

polipeptídeo de ligação ao anticorpo, polipeptídeo de fusão de ligação ao anticorpo, e material de adsorção

Info

Publication number
BR112017006536A2
BR112017006536A2 BR112017006536A BR112017006536A BR112017006536A2 BR 112017006536 A2 BR112017006536 A2 BR 112017006536A2 BR 112017006536 A BR112017006536 A BR 112017006536A BR 112017006536 A BR112017006536 A BR 112017006536A BR 112017006536 A2 BR112017006536 A2 BR 112017006536A2
Authority
BR
Brazil
Prior art keywords
antibody binding
polypeptide
adsorption material
antibody
fusion polypeptide
Prior art date
Application number
BR112017006536A
Other languages
English (en)
Inventor
Minami Koichi
Original Assignee
Fujifilm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp filed Critical Fujifilm Corp
Publication of BR112017006536A2 publication Critical patent/BR112017006536A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)

Abstract

proporcionam-se um polipeptídeo de ligação ao anticorpo conforme apre-sentado em qualquer uma das seq id nos: 1 a 18 e um material de adsorção de um anticorpo ou derivado de anticorpo no qual o polipeptídeo de ligação ao anticor-po está imobilizado sobre um veículo insolúvel em água. estes polipeptídeo de liga-ção ao anticorpo e material de adsorção têm propriedades de ligação ao anticorpo e seletividade excelentes, e também resistência ao álcali e estabilidade temporária excelentes.
BR112017006536A 2014-09-29 2015-09-04 polipeptídeo de ligação ao anticorpo, polipeptídeo de fusão de ligação ao anticorpo, e material de adsorção BR112017006536A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014199131 2014-09-29
JP2015073147 2015-03-31
PCT/JP2015/075157 WO2016052073A1 (ja) 2014-09-29 2015-09-04 抗体結合性ポリペプチド、抗体結合性融合ポリペプチドおよび吸着材料

Publications (1)

Publication Number Publication Date
BR112017006536A2 true BR112017006536A2 (pt) 2017-12-19

Family

ID=55630116

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017006536A BR112017006536A2 (pt) 2014-09-29 2015-09-04 polipeptídeo de ligação ao anticorpo, polipeptídeo de fusão de ligação ao anticorpo, e material de adsorção

Country Status (10)

Country Link
US (1) US10450344B2 (pt)
EP (1) EP3202774A4 (pt)
JP (1) JP6328781B2 (pt)
KR (1) KR101964619B1 (pt)
CN (1) CN106795202B (pt)
BR (1) BR112017006536A2 (pt)
CA (1) CA2962241A1 (pt)
RU (1) RU2663998C1 (pt)
SG (1) SG11201702539UA (pt)
WO (1) WO2016052073A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017022095A2 (pt) 2015-04-13 2018-07-03 Fujifilm Corporation método para produção de transportador imobilizado de peptídeo de cadeia curta e transportador imobilizado de peptídeo de cadeia curta
EP3487538A1 (en) * 2016-07-22 2019-05-29 Nektar Therapeutics Conjugates of a factor viii moiety having an oxime-containing linkage
CA3094112A1 (en) 2018-03-28 2019-10-03 Bristol-Myers Squibb Company Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use
MX2021000016A (es) 2018-07-03 2021-03-09 Bristol Myers Squibb Co Formulaciones de factor de crecimiento de fibroblastos (fgf-21).
WO2020027237A1 (ja) * 2018-08-01 2020-02-06 国立大学法人鹿児島大学 ペプチド融合タンパク質

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK528285D0 (da) * 1985-11-15 1985-11-15 Novo Industri As Peptider samt praeparater indeholdende disse
DE3887750T2 (de) * 1987-11-20 1994-09-15 Creative Biomolecules Inc Selektive entfernung von immunkomplexen.
US5084398A (en) 1987-11-20 1992-01-28 Creative Biomolecules Selective removal of immune complexes
US5932483A (en) * 1990-10-16 1999-08-03 Northwestern University Synthetic peptide and its uses
US6420518B1 (en) * 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
AU2003903317A0 (en) * 2003-06-27 2003-07-10 Proteome Systems Intellectual Property Pty Ltd Method of isolating a protein
SE0301987D0 (sv) * 2003-07-04 2003-07-04 Affibody Ab New polypeptide
DK1641818T3 (da) * 2003-07-04 2009-03-16 Affibody Ab Polypeptider der har bindingsaffinitet for HER2
US9238810B2 (en) 2008-06-05 2016-01-19 Affibody Ab Polypeptide
EP2208787A1 (en) * 2009-01-19 2010-07-21 Université de Liège A recombinant alpha-hemolysin polypeptide of Staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted
FR2951548B1 (fr) 2009-10-15 2011-11-11 Biomerieux Sa Procede de caracterisation d'au moins un microorganisme par spectrometrie de masse
US20130052209A1 (en) 2010-04-23 2013-02-28 Purdue Research Foundation Protein drug formulations and packages
JP5933526B2 (ja) 2011-03-25 2016-06-08 株式会社カネカ 免疫グロブリン結合性新規ポリペプチド

Also Published As

Publication number Publication date
CA2962241A1 (en) 2016-04-07
CN106795202A (zh) 2017-05-31
SG11201702539UA (en) 2017-04-27
RU2663998C1 (ru) 2018-08-14
WO2016052073A1 (ja) 2016-04-07
JPWO2016052073A1 (ja) 2017-06-01
JP6328781B2 (ja) 2018-05-23
KR20170042792A (ko) 2017-04-19
EP3202774A4 (en) 2017-08-16
US20170210777A1 (en) 2017-07-27
US10450344B2 (en) 2019-10-22
CN106795202B (zh) 2020-10-30
EP3202774A1 (en) 2017-08-09
KR101964619B1 (ko) 2019-04-02

Similar Documents

Publication Publication Date Title
BR112017006536A2 (pt) polipeptídeo de ligação ao anticorpo, polipeptídeo de fusão de ligação ao anticorpo, e material de adsorção
PH12020550205A1 (en) IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
PH12018501882A1 (en) Binding proteins and methods of use thereof
MX2023001834A (es) Anticuerpos antimiostatina, polipeptidos que contienen regiones fc variantes, y metodos de uso.
PH12018501280A1 (en) Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use
IL290135A (en) Polypeptides with n-tertazine or tetracyclooctane residues
BR112016022841A2 (pt) cadeia j modificada
WO2014144960A3 (en) Fc variants
EA201990017A1 (ru) Антитела к миостатину и способы их применения
MX2016008539A (es) Variantes de region fc con propiedades de union a receptor fc neonatal (fcrn) modificadas y de union a proteina a mantenidas.
EA201791426A1 (ru) Полипептид и иммуномодуляция
MX2016008782A (es) Variantes de region fc con union mejorada de la proteina a.
CY1120055T1 (el) Αντικαρκινικη πρωτεϊνη συντηξης
WO2013152351A3 (en) Fusion polypeptides and methods of use thereof
WO2014150877A3 (en) Anti-tau antibodies and methods of use
EP3169731A4 (en) Asphalt coatings for roofing waterproof membranes, waterproof membranes including the asphalt coatings and methods for making the asphalt coatings
MY188784A (en) Il-17a-binding polypeptides
BR112017009560A2 (pt) preparação de material microporoso compósito baseado quitosana e suas aplicações
BR112015003724A2 (pt) polipeptídeo isolado, composição, uso de uma composição, polinucleotídeo isolado, constructo de ácido nucleico ou vetor de expressão, célula hospedeira recombinante, e, métodos de produção de um polipeptídeo e de produção de uma proteína.
WO2014152946A3 (en) Polypeptides for treating and/or limiting influenza infection
WO2014144095A3 (en) Compositions comprising d-amino acid peptides and methods of production and use thereof for inhibiting autoantibodies
CY1121414T1 (el) Παρασκευη ιικου φορεα
BR112016017644A2 (pt) conjugados de fator vii
EP3491085A4 (en) WATER-BASED MOUTHPIECES PROVIDING SUPERIOR DURABILITY
CR20150477A (es) Polipéptidos de il-22 y proteínas de fusión de il-22 fc y métodos de uso

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements